Gastrointestinal Stromal Tumor (GIST) Clinical Trials
3 recruiting trials for Gastrointestinal Stromal Tumor (GIST). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Gastrointestinal Stromal Tumor (GIST) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Azienda Ospedaliera di Padova (1), Stanford University (1), National Cancer Institute (NCI) (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood draw (procedure, 1 trial), followed by Tissue tumor biopsy.
Track Gastrointestinal Stromal Tumor (GIST) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
An International Study on Pediatric Patients With Rare Tumors.
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood...
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Objective: To follow people with GISTs and collect tumor tissue so that it can be studied in the lab. Eligibility: People age 6 and older who have a GIST. Design:...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Gastrointestinal Stromal Tumor (GIST), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Gastrointestinal Stromal Tumor (GIST), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Gastrointestinal Stromal Tumor (GIST), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.